The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2024 | Advice for managing pregnancy in patients with CML
Elisabetta Abruzzese, MD, PhD, S. Eugenio University Hospital, Rome, Italy, emphasizes the importance of addressing reproductive concerns at the time of diagnosis for patients with chronic myeloid leukemia (CML). She highlights that, although many physicians were previously unfamiliar with managing such situations, it is now possible to handle them effectively, and all physicians should be aware of these options. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
The first thing we must say is that reproduction should be a subject that must be afforded at diagnosis. As soon as the patient, either female or male patients, are coming to our attention at diagnosis, we should afford this subject because we all know how to manage this now and we know that it is possible and all physicians should be aware of this possibility. Because up until a few years ago, many of the physicians, hematologists or also obstetricians, they do not know how to deal with that and they just suggested to stop the pregnancy or to not proceed with the pregnancy desire.
